A Study of Pembrolizumab With Lenvatinib in Women With Advanced Uterine Carcinosarcoma

NCT05147558 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Uterine Carcinosarcoma
Advanced Uterine Carcinosarcoma

Interventions

DRUG: Pembrolizumab
DRUG: Lenvatinib

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]